Darnytsia Takes Part in the Ukraine-EU Integration: Healthcare Conference
Darnytsia Pharmaceutical Company took part in the Ukraine-EU Integration: Healthcare conference organized by the Ministry of Health of Ukraine together with the European Commission.
This is one of the key events for the medical community of Ukraine, during which the European integration processes in the field of healthcare, which are important for our country, were discussed.
Despite the full-scale war, Ukraine confidently holds the European integration vector. In particular, it harmonizes legislation with EU requirements, ensures the availability and affordability of high-quality medicines not only in Ukraine, but also in the world, conducts clinical trials and implements powerful digital integration with the EU in the field of healthcare.
Important European integration achievements include the adoption of Law of Ukraine On Medicines, preparation of legislative regulation of medical products, introduction of e-prescribing.
Ukrainian pharmaceutical companies are important participants in the European integration reform. Thus, Darnytsia is a modern, world-class production, which is confirmed by national and international certificates. The leader of pharmaceutical production of Ukraine adheres to quality standards at all stages of creation of medicines.
Darnytsia production facilities meet the requirements of Good Manufacturing Practice (GMP).
GMP certificates are constantly renewed both by the State Service of Ukraine on Medicines and Medicinal Activities Control, and by GMP from EU countries.
Darnytsia production is equipped with the latest equipment from leaders in their fields - Glatt, Korsh, Schafer, Wipotec-OCS (Germany), Fette (France), Marchesini Group, IMA Group (Italy), Steris (Ireland).
“Darnytsia is an innovative company capable of providing our state and EU countries with high-quality and safe medicines. Our medicines meet the requirements of European standards. After all, we have been following GMP requirements since 2002. In general, our company is at the forefront of the latest technologies. Thus, the robotic warehouse at Darnytsia became operational in 2008, and we have been actively using artificial intelligence since 2021. Today, we are supporting the European integration path of our country with our achievements,” Serhii Onyshchenko, Member of the Supervisory Board of Darnytsia Pharmaceutical Company, said during his speech at the conference.